deltatrials
Completed PHASE2 INTERVENTIONAL 3-arm NCT04495283

A Phase 2 Study to Evaluate Pregabalin and Acetaminophen Compared to Acetaminophen and Placebo in Subjects Undergoing Bunionectomy

A Phase 2, Randomized, Double-Blind, Placebo- and Comparator-Controlled Trial to Evaluate the Safety and Efficacy of Combination of Pregabalin and Acetaminophen Compared to Acetaminophen and Placebo in Subjects Undergoing Bunionectomy

Sponsor: Nevakar Injectables, Inc.

Updated 7 times since 2020 Last updated: Oct 25, 2021 Started: Jul 28, 2020 Primary completion: Nov 12, 2020 Completion: Nov 12, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04495283, this PHASE2 trial focuses on Postoperative Pain and remains completed. Sponsored by Nevakar Injectables, Inc., it has been updated 7 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Aug 2020 – ~Sep 2020 · 31 days · monthly snapshotNot Yet Recruiting~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshotNot Yet Recruiting~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshotNot Yet Recruiting~Apr 2021 – ~Dec 2021 · 8 months · monthly snapshotCompleted~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

7 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Dec 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Apr 2021 — Dec 2021 [monthly]

    Completed PHASE2

    Status: Not Yet RecruitingCompleted

  5. Jan 2021 — Apr 2021 [monthly]

    Not Yet Recruiting PHASE2

Show 2 earlier versions
  1. Sep 2020 — Jan 2021 [monthly]

    Not Yet Recruiting PHASE2

  2. Aug 2020 — Sep 2020 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Jul 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Nevakar Injectables, Inc.
  • Nevakar, Inc.
Data source: Nevakar, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .